ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.

ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39658846

about

Gene expression profiling of liver cancer stem cells by RNA-sequencing RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.Tetrandrine Suppresses Cancer Angiogenesis and Metastasis in 4T1 Tumor Bearing Mice.Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma.Endocan: A new marker for cancer and a target for cancer therapy.A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion Expressions of Endocan in Patients with Meningiomas and Gliomas Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression Endocan: a novel circulating proteoglycan.Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells.Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells.Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.Endocan silencing induces programmed cell death in hepatocarcinoma.Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.

P2860

Q28483663-62628D34-4E1B-474D-AF76-44067411FA31 Q34063655-8A8E5977-7DCB-4B8F-BB73-C1B1714A2CBF Q34769302-423D725A-D4F0-4961-B690-E5CE3CABB06A Q35067738-2BE47AE0-F7C4-49EF-A8C5-53082AB87FED Q35568894-272D33D5-33D2-48DB-8949-980AB4B98D26 Q35681482-4E43FA4E-5CA1-4488-A54D-A830A0EBE43F Q36704453-C8C76DFD-A130-4F81-96B2-FE0F3DCB7FC2 Q37162853-3F5C1400-1B63-4AD6-A09D-E80DB1044F09 Q37657319-C41D8023-2F21-4271-97F2-2477CFFD15AA Q37706719-B237A7FF-84D5-4E95-BAA8-6C6C3B66AD8D Q38299725-9DA3B8B2-1321-4F63-B9DC-17E0F74DA126 Q39431959-47B9D77E-336B-412E-9175-41EDA7BBF696 Q40087980-AE4FEE41-3B3A-4A5F-807C-C98CEF9BCDC1 Q41472390-B77DFCEA-1A34-467E-BD01-4FC7138645E0 Q42283730-451AD094-E366-436C-AF88-577AFA2FE682 Q45873067-E2B6FDB9-708B-4410-BB29-EA93B5450090 Q47105893-8A079FE2-6C9F-429D-8D67-F2C9EEC63E2A Q47139612-3D297F5D-B370-42DA-A966-EA163CB11F1C Q51275626-F7894ECE-A1AA-4560-A3EF-04345DFD47B8 Q53246001-E3F98F58-58DB-4567-930C-4BD01BFD56A8

P2860

ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39658846

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@en

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@nl

type

label

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@en

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@nl

prefLabel

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@en

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@nl

P1433

Q39658846-B0113EF2-4D0F-491D-B9A8-B7A2E116079A

P1476

Q39658846-9D3CB8B4-1F02-4E58-A1F6-B84F6C5A355F

P2093

Q39658846-1E424A67-F39E-4E06-A7D3-4DBF99C788DF

Q39658846-25818321-5678-4309-AA31-32A5AE8C0B9A

Q39658846-5AA3BEF0-7250-43DE-8BFE-AC1E7231350B

Q39658846-953D00B6-8D59-4AA7-8B4D-04889FE12E7D

Q39658846-9647F5B9-A6B6-4FD8-BF27-ACB531AC96A9

Q39658846-9A1F1FC2-07A8-4B03-B0FF-65B220938817

Q39658846-9EF4FAF7-50E5-4FFB-9DE2-EBB095F3A66E

Q39658846-ACAC5204-9A05-4277-BE91-6189EFA0E79B

Q39658846-CC49FAC5-FB4E-45D2-A7C8-9C7158E7A2F8

Q39658846-D2CBB947-1BA3-4DC0-9AB7-1D4749B16F88

P2860

Q39658846-0D7B73D4-8246-46E1-821D-3E3703EF573D

Q39658846-112A0366-C906-49CB-ABAA-EFB80CAAEB7D

Q39658846-230E7D49-B54E-48DA-B779-09E4C68EBF7F

Q39658846-3132F008-D963-455F-AA03-20439E9FECDE

Q39658846-3140C743-37D6-4E11-B974-9C679D5E2B5A

Q39658846-32168D7F-E272-4144-BCEB-EEB3105AB8B0

Q39658846-376C2373-62A8-42FB-A92F-23DAA70DDD42

Q39658846-4A48978D-2B07-4BAB-A3D1-37211C8AA4D0

Q39658846-56658416-DB02-4CA1-8120-D13EF3263D5C

Q39658846-5EA913DA-27DC-4D0B-8581-1CC8B66BB778

P2888

Q39658846-45A4C527-5807-41EB-9084-C5D6BEC41A94

P304

Q39658846-ED6BFDF6-FABB-431F-9E07-414258AC274D

P31

Q39658846-43844950-C66D-4051-B68F-399B5F5DE9B5

P356

Q39658846-D116626D-4A4A-48EB-A430-40721D9081F5

P433

Q39658846-10F46E9E-CF66-4BB4-8C8E-2ACD69116FA9

P478

Q39658846-99DDD04C-527B-4801-A70D-3A8CAB0FE046

P577

Q39658846-02B5758B-73DB-4B43-9C78-9C3118E07999

P698

Q39658846-E7278DBB-8203-4930-9E62-802F0D77D296

P356

S00726-010-0729-6

P1433

P1476

ESM-1 silencing decreased cell ...... n in hepatocellular carcinoma.

@en

P2093

Chung Il Lee

http://www.w3.org/2001/XMLSchema#string

Dae Ghon Kim

http://www.w3.org/2001/XMLSchema#string

Eun Young Song

http://www.w3.org/2001/XMLSchema#string

Hee Gu Lee

http://www.w3.org/2001/XMLSchema#string

Jae Wha Kim

http://www.w3.org/2001/XMLSchema#string

Jong Wan Kim

http://www.w3.org/2001/XMLSchema#string

Na Young Ji

http://www.w3.org/2001/XMLSchema#string

Pil Je Park

http://www.w3.org/2001/XMLSchema#string

Seung Kew Yoon

http://www.w3.org/2001/XMLSchema#string

Young Il Yeom

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Cell migration: a physically integrated molecular process

CDK inhibitors: positive and negative regulators of G1-phase progression

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.

PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells

Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies.

ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines.

Serum tumor markers for detection of hepatocellular carcinoma.

P2888

s00726-010-0729-6

P304

1003-1013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-010-0729-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20821239

http://www.w3.org/2001/XMLSchema#string